{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:56:48Z","timestamp":1782755808048,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T00:00:00Z","timestamp":1550275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.nefro.2018.11.011","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T18:53:35Z","timestamp":1552935215000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Epidemiolog\u00eda de la hiperpotasemia en la enfermedad renal cr\u00f3nica"],"prefix":"10.1016","volume":"39","author":[{"given":"Lara","family":"Belmar Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Rodrigo","family":"Galabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Bada da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bentanachs Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Fern\u00e1ndez Fresnedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino","family":"Pi\u00f1era Haces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Palomar Fontanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ruiz San Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Luis Mart\u00edn","family":"de Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2018.11.011_bib0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0749-0704(18)30329-4","article-title":"Endocrine crises hyperkalemia","volume":"7","author":"Williams","year":"1991","journal-title":"Crit Care Clin."},{"key":"10.1016\/j.nefro.2018.11.011_bib0245","first-page":"c8","article-title":"Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: The role of race","volume":"120","author":"Hayes","year":"2012","journal-title":"Nephron Clin Pract."},{"key":"10.1016\/j.nefro.2018.11.011_bib0250","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2215\/CJN.09340817","article-title":"Hyperkalemia across the continuum of kidney function","volume":"13","author":"Palmer","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0260","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archinte.1977.03630190010005","article-title":"Nonuremic diabetic hyperkalemia Possible role of insulin deficiency","volume":"137","author":"DeFronzo","year":"1977","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/diab.28.3.237","article-title":"Hyporeninemic hypoaldosteronism in diabetes mellitus. Studies of the autonomic nervous system's control of renin release","volume":"28","author":"Tuck","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.nefro.2018.11.011_bib0270","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors","volume":"5","author":"Weir","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0275","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrneph.2014.168","article-title":"Management of hyperkalaemia in chronic kidney disease","volume":"10","author":"Kovesdy","year":"2014","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0280","unstructured":"Latts LM, Reaven NL, Funk SE, McGaughey KJ, Adamson RT. Hyperkalemia is prevalent in patients with cardiorenal comorbidities. Poster presented at: The International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 20th Annual International Meeting; May 16-20, 2015; Philadelphia, PA."},{"key":"10.1016\/j.nefro.2018.11.011_bib0285","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2215\/CJN.05850809","article-title":"Serum potassium and outcomes in CKD: Insights from the RRI-CKD cohort study","volume":"5","author":"Korgaonkar","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0290","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000437151","article-title":"Serum potassium end-stage renal disease and mortality in chronic kidney disease","volume":"41","author":"Nakhoul","year":"2015","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0295","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.116.07363","article-title":"Antihypertensive medications and the prevalence of hyperkalemia in a large health system","volume":"67","author":"Chang","year":"2016","journal-title":"Hypertension."},{"issue":"11 Suppl","key":"10.1016\/j.nefro.2018.11.011_bib0300","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.nefro.2018.11.011_bib0305","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1525-1497.1997.07128.x","article-title":"Hyperkalemia in the elderly: Drugs exacerbate impaired potassium homeostasis","volume":"12","author":"Perazella MA1","year":"1997","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ki.1980.14","article-title":"Hyperkalemia and hyporeninemic hypoaldosteronism","volume":"17","author":"DeFronzo","year":"1980","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2018.11.011_bib0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-8227(89)90001-6","article-title":"Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus","volume":"7","author":"Pun","year":"1989","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.nefro.2018.11.011_bib0320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0009-8981(82)90161-9","article-title":"Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients","volume":"120","author":"McNair","year":"1982","journal-title":"Clin Chim Acta."},{"issue":"Suppl 3","key":"10.1016\/j.nefro.2018.11.011_bib0325","first-page":"87","article-title":"Alteraciones electrol\u00edticas y del equilibrio \u00e1cido-base en la enfermedad renal cr\u00f3nica avanzada","volume":"28","author":"Alc\u00e1zar Arroyo","year":"2008","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2018.11.011_bib0330","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0891-6632(90)90057-C","article-title":"Hyperkalemia in diabetes mellitus","volume":"4","author":"Uribarri","year":"1990","journal-title":"J Diabet Complications."},{"key":"10.1016\/j.nefro.2018.11.011_bib0340","doi-asserted-by":"crossref","first-page":"488","DOI":"10.12998\/wjcc.v2.i10.488","article-title":"Diabetes mellitus and electrolyte disorders","volume":"2","author":"Liamis","year":"2014","journal-title":"World J Clin Cases."},{"key":"10.1016\/j.nefro.2018.11.011_bib0345","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0350","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2215\/CJN.00960112","article-title":"Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort","volume":"7","author":"Torl\u00e9n","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0355","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4321\/S1137-66272011000100014","article-title":"Acidosis l\u00e1ctica por metformina desencadenada por una insuficiencia renal aguda","volume":"34","author":"Mac\u00edas-Robles","year":"2011","journal-title":"An Sist Sanit Navar."},{"key":"10.1016\/j.nefro.2018.11.011_bib0360","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis","volume":"31","author":"Bodmer","year":"2008","journal-title":"Diabetes Care."},{"key":"10.1016\/j.nefro.2018.11.011_bib0365","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9343(81)90182-0","article-title":"Changes in plasma potassium concentration during acute acid-base disturbances","volume":"71","author":"Adrogu\u00e9","year":"1981","journal-title":"Am J Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0370","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MAJ.0b013e3181836ac7","article-title":"Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: Risk factors analysis","volume":"336","author":"Maddirala","year":"2008","journal-title":"Am J Med Sci."},{"key":"10.1016\/j.nefro.2018.11.011_bib0375","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.116.07363","article-title":"Antihypertensive medications and the prevalence of hyperkalemia in a large health system","volume":"67","author":"Chang","year":"2016","journal-title":"Hypertension."},{"key":"10.1016\/j.nefro.2018.11.011_bib0380","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/0886022X.2012.717478","article-title":"Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: A safety concern?","volume":"34","author":"Yildirim","year":"2012","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefro.2018.11.011_bib0385","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0895-7061(98)00117-4","article-title":"Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors","volume":"11","author":"Wynckel","year":"1998","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.nefro.2018.11.011_bib0390","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors","volume":"5","author":"Weir","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11 Suppl","key":"10.1016\/j.nefro.2018.11.011_bib0395","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care."},{"issue":"10003","key":"10.1016\/j.nefro.2018.11.011_bib0400","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(15)00418-3","article-title":"The double challenge of resistant hypertension and chronic kidney disease","volume":"386","author":"Rossignol","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.nefro.2018.11.011_bib0405","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/j.1523-1755.2000.00381.x","article-title":"ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure","volume":"58","author":"Bakris","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2018.11.011_bib0410","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.nefro.2018.11.011_bib0415","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0420","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2007.07.067","article-title":"Incidence and predictors of hyperkalemia in patients with heart failure: An analysis of the CHARM Program","volume":"50","author":"Desai","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0425","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2018.11.011_bib0430","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.108.807917","article-title":"Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: Balancing risk and benefit","volume":"118","author":"Desai","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.nefro.2018.11.011_bib0435","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"30","author":"Raebel","year":"2012","journal-title":"Cardiovasc Ther."},{"key":"10.1016\/j.nefro.2018.11.011_bib0440","doi-asserted-by":"crossref","first-page":"e005428","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia after initiating renin-angiotensin system blockade: The Stockholm Creatinine Measurements (SCREAM) Project","volume":"6","author":"Bandak","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.nefro.2018.11.011_bib0445","first-page":"43","article-title":"Potassium-binding agents for the clinical management of hyperkalemia","volume":"41","author":"Chaitman","year":"2016","journal-title":"P T."},{"key":"10.1016\/j.nefro.2018.11.011_bib0450","doi-asserted-by":"crossref","unstructured":"Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: A systematic review. Am J Med. 2013 126(3):264.e9-24. DOI 10.1016\/j.amjmed.2012.08.016Epub 2013.","DOI":"10.1016\/j.amjmed.2012.08.016"},{"key":"10.1016\/j.nefro.2018.11.011_bib0455","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-exchange resins for the treatment of hyperkalemia: Are they safe and effective?","volume":"21","author":"Sterns","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.11.011_bib0460","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2018.11.011_bib0465","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2018.11.011_bib0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15420\/cfr.2017.2.1","article-title":"How to improve adherence to life-saving heart failure treatments with potassium binders","volume":"3","author":"Lainscak","year":"2017","journal-title":"Card Fail Rev."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519300451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519300451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:53:25Z","timestamp":1759323205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699519300451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0211699519300451"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2018.11.011","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiolog\u00eda de la hiperpotasemia en la enfermedad renal cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2018.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}